Unfortunately, PAX-8 staining analysis was performed in 1 of the previous 26 cases of OMM (Table 3), which also suggested that we could improve PAX-8 staining rate in patients with mesothelioma as much as possible in the future, providing more accurate information for the formulation of future guidelines or consensus. This evidence concerns the gene PAX8 and mesothelioma.